conv.

← The whole story
Health
GLP-1 drugs for obese children surge from rare to 9% of young users in US

Novo Nordisk reports 40% of children in trial no longer classified as obese

1 Sep 22 · 2d ago · 7 articles · 1 source · development 1 of 2

Novo Nordisk, the maker of Wegovy, reported that 40% of children aged 6–12 with severe obesity who received weekly injections during a 68-week clinical trial were no longer classified as having obesity, demonstrating clinical effectiveness.

Novo Nordisk reports 40% of children in trial no longer classified as obese
New Scientist

Babak Orandi Lead researcher, NYUDanielle Longmore Pediatric researcher, Murdoch Children's Research InstituteNovo Nordisk GLP-1 drug manufacturer

The whole story articles the bright band is this development · numbered dots are the others · click one to jump

Peak 3 pieces in one hour at Sep 21, 3 PM; 11 pieces over 2 days (11 articles) Sep 21, 3 PM — 3 pieces · 3 articles — Google News 3Sep 21, 4 PM — 1 piece · 1 article — Google News 1Sep 21, 5 PM — quietSep 21, 6 PM — quietSep 21, 7 PM — quietSep 21, 8 PM — quietSep 21, 9 PM — quietSep 21, 10 PM — quietSep 21, 11 PM — 3 pieces · 3 articles — Google News 3Sep 22, 12 AM — quietSep 22, 1 AM — quietSep 22, 2 AM — quietSep 22, 3 AM — quietSep 22, 4 AM — quietSep 22, 5 AM — quietSep 22, 6 AM — 1 piece · 1 article — Newswires 1Sep 22, 7 AM — quietSep 22, 8 AM — quietSep 22, 9 AM — quietSep 22, 10 AM — quietSep 22, 11 AM — quietSep 22, 12 PM — quietSep 22, 1 PM — quietSep 22, 2 PM — quietSep 22, 3 PM — quietSep 22, 4 PM — 2 pieces · 2 articles — Google News 2Sep 22, 5 PM — quietSep 22, 6 PM — quietSep 22, 7 PM — quietSep 22, 8 PM — quietSep 22, 9 PM — quietSep 22, 10 PM — quietSep 22, 11 PM — quietYesterday, 12 AM — quietYesterday, 1 AM — quietYesterday, 2 AM — quietYesterday, 3 AM — quietYesterday, 4 AM — quietYesterday, 5 AM — quietYesterday, 6 AM — quietYesterday, 7 AM — quietYesterday, 8 AM — quietYesterday, 9 AM — quietYesterday, 10 AM — quietYesterday, 11 AM — 1 piece · 1 article — Google News 1Yesterday, 12 PM — quietYesterday, 1 PM — quietYesterday, 2 PM — quietYesterday, 3 PM — quietYesterday, 4 PM — quietYesterday, 5 PM — quietYesterday, 6 PM — quietYesterday, 7 PM — quietYesterday, 8 PM — quietYesterday, 9 PM — quietYesterday, 10 PM — quietYesterday, 11 PM — quietToday, 12 AM — quiet 12
1Novo Nordisk reports 40% of children in…2Experts weigh benefits of treating severe…
Sep 22yesterdaynow · 1:00 AM ET

Reported in the same hours no headline names this development itself — these 2 claims were published in its stretch

  1. 4 outlets GLP-1s Linked to Nutritional Deficiencies in Teens

    first by Technology Networks, 2d ago · also Google News · Health, Northwestern Now News, Medical Xpress

    2 more headlines
  2. 2 outlets Use of GLP-1 Receptor Agonists Increasing Among Children With Obesity

    first by Pulmonology Advisor, 2d ago · also Lelezard

    1 more headline

All 2 developments of GLP-1 drugs for obese children surge from rare to 9% of… →

NewswiresGoogle News